These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22411548)

  • 41. [French validation of the Multiple Sclerosis International Quality of Life Questionnaire].
    Baumstarck-Barrau K; Pelletier J; Simeoni MC; Auquier P;
    Rev Neurol (Paris); 2011; 167(6-7):511-21. PubMed ID: 21420136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Quality of life in patients with essential arterial hypertension. Part II: The effect of clinical factors].
    Klocek M; Kawecka-Jaszcz K
    Przegl Lek; 2003; 60(2):101-6. PubMed ID: 12939856
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improving quality of life in hypertension management using a fixed-dose combination of olmesartan and amlodipine in primary care.
    Bramlage P; Wolf WP; Fronk EM; Stuhr T; Erdlenbruch W; Wasem J; Ketelhut R; Schmieder RE
    Expert Opin Pharmacother; 2010 Dec; 11(17):2779-90. PubMed ID: 20929435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation of the French version of the arthritis impact measurement scales 2 and comparison with the french version of the Nottingham Health Profile. "Quality of Life in Rheumatology" Task Force.
    Pouchot J; Guillemin F; Coste J; Brégeon C; Sany J
    Rev Rhum Engl Ed; 1996 Jun; 63(6):389-404. PubMed ID: 8817749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of high blood pressure in Germany.
    Faulhaber HD; Luft FC
    Am J Hypertens; 1998 Jun; 11(6 Pt 1):750-3. PubMed ID: 9657639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Doing better, feeling worse.
    Lancet; 1990 Oct; 336(8722):1037-8. PubMed ID: 1977025
    [No Abstract]   [Full Text] [Related]  

  • 47. Quality of life issues in hypertension: consequences of diagnosis and considerations in management.
    Wenger NK
    Am Heart J; 1988 Aug; 116(2 Pt 2):628-32. PubMed ID: 3293406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Validity and reliability of FANTASTIC an instrument for measuring the life style in Mexican patients with arterial hypertension].
    López-Carmona JM; Rodríguez-Moctezuma R; Munguía-Miranda C; Hernández-Santiago JL; Casas de la Torre E
    Aten Primaria; 2000 Nov; 26(8):542-9. PubMed ID: 11149187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality of life claims in trials of anti-hypertensive therapy.
    Hunt SM
    Qual Life Res; 1997 Mar; 6(2):185-91. PubMed ID: 9161118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of antihypertensive therapy on quality of life].
    Ostroumova OD; Mamaev VI; Abakumov YE; Batutina AM; Nesterova MV
    Kardiologiia; 2003; 43(3):99-102. PubMed ID: 12913990
    [No Abstract]   [Full Text] [Related]  

  • 51. SPRINT Results Are Life-Saving, Guideline-Changing, and Hypertension Research-Intensifying.
    Tsioufis C; Tousoulis D
    Hellenic J Cardiol; 2015; 56(6):529-30. PubMed ID: 26685302
    [No Abstract]   [Full Text] [Related]  

  • 52. Quality of life in geriatric hypertension.
    Palmer RM; DeBor L
    J Am Geriatr Soc; 1989 Mar; 37(3):288. PubMed ID: 2918203
    [No Abstract]   [Full Text] [Related]  

  • 53. Changing criteria for mild hypertension: effect on number of patients treated.
    Millar JA
    Lancet; 1988 Nov; 2(8620):1138. PubMed ID: 2903347
    [No Abstract]   [Full Text] [Related]  

  • 54. Instrument to evaluate the behavioral intention of hypertensive people when taking anti-hypertensives.
    Almeida TDCF; Sousa MM; Gouveia BLA; Olinda RA; Freire MEM; Oliveira SHDS
    Rev Bras Enferm; 2021; 74(1):e20200192. PubMed ID: 33787791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality Focus: Hypertension: The Challenges of Appropriate Diagnosis and Treatment Continue.
    Schroeder S
    S D Med; 2018 Feb; 71(2):91. PubMed ID: 29990419
    [No Abstract]   [Full Text] [Related]  

  • 56. INSAF-HAS: a tool to select patients with hypertension for pharmaceutical care.
    Girolineto BMP; Oliveira AM; Gonçalves AMRF; Campos MSA; Pereira LRL
    Einstein (Sao Paulo); 2020; 18():eAO4858. PubMed ID: 31851225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Quality of life among the elderly hypertensive population in two areas of Zhejiang province].
    Zhou B; Chen K; Yu YX; Wang H; Wang JF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Apr; 31(4):474-5. PubMed ID: 22993816
    [No Abstract]   [Full Text] [Related]  

  • 58. [Characteristics and management of hypertension in the elderly].
    Ogihara T
    Nihon Ronen Igakkai Zasshi; 1993 Nov; 30(11):932-40. PubMed ID: 8295351
    [No Abstract]   [Full Text] [Related]  

  • 59. Refractory hypertension: what do we know so far?
    Muxfeldt ES; Chedier B
    J Hum Hypertens; 2021 Mar; 35(3):181-183. PubMed ID: 32873873
    [No Abstract]   [Full Text] [Related]  

  • 60. Hypertension--a case for treatment.
    Dall JL
    Age Ageing; 1979; Suppl():36-8. PubMed ID: 525535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.